Le Lézard
Classified in: Health
Subjects: CCA, BFA

Perrigo to Release Second Quarter 2023 Financial Results and Present at an Industry Growth Conference


DUBLIN, July 25, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its second quarter 2023 financial results on Tuesday, August 8, 2023, and will host a conference call beginning at 8:30 A.M. (EST).

Separately, President and CEO, Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the Canaccord Genuity 43rd Annual Growth Conference in Boston on Wednesday, August 9th at 10:30 A.M. (EST). The presentation link to the live webcast will be available within the investor relations section of the Perrigo website.

The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 888-317-6003, International 412-317-6061, and reference ID # 6916237. A taped replay of the call will be available beginning at approximately 12:00 P.M. (EST) Tuesday, August 8, until midnight Tuesday, August 15, 2023. To listen to the replay, dial 877-344-7529, International 412-317-0088, and use access code 4782572.

About Perrigo 

Perrigo Company plc (NYSE: PRGO) is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Visit Perrigo online at www.perrigo.com. 

Forward-Looking Statements

This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Litigation Securities Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties, and other factors?many of which beyond the Company's control?that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2022.

SOURCE Perrigo Company plc


These press releases may also interest you

at 17:15
The Inner Circle acknowledges, Sharon E. Oster, MD as a Pinnacle Lifetime Member
Prominently featured in The Inner Circle, Sharon E. Oster, MD, is acknowledged as a Pinnacle Life Member for her contributions to the fields of Internal Medicine and Infectious Diseases. Dr. Oster began her scholarship at the University of Colorado...

at 17:10
Aronia Berries Market size is set to grow by USD 501.5 million from 2024-2028, Health benefits of aronia berries boost the market, Technavio
The global aronia berries market size is estimated to grow by USD 501.5 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 9.64% during the forecast period. Health benefits of aronia berries is driving...

at 17:09
Two weeks remain in consultations to help 2SLGBTQI+ seniors age well at home
Every senior deserves to age in health, in safety and in dignity. Everyone should have the choice to age at home, in their communities, on their terms. That includes 2SLGBTQI+ Canadians. However, many 2SLGBTQI+ seniors do not have all of the supports...

at 17:00
VitalHub Corp. Announces Results of Annual General and Special Meeting of Shareholders
VITALHUB CORP.   (the "Company" or "VitalHub") today reported a summary of the voting results of its Annual General and Special Meeting of Shareholders (the "Meeting"). Results of the Meeting The Company is reporting the voting results of its...

at 17:00
Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Exploring the Rapid Rise of Osteoarthritis" on July 9, 2024
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") , a clinical-stage biotechnology company leveraging its proprietary DiffuSpheretm technology to optimize drug delivery...

at 16:59
Internationally Recognized Physician Specializing in Otology Leaves Lasting Legacy
Dr. Bill Lippy, an internationally recognized physician and philanthropist, passed away June 29, 2024 surrounded by his loving family. Dr. Lippy, was born in Niles, Ohio in 1928. After graduating from Oberlin College, Lippy completed...

More news about Health...


News published on and distributed by: